How many insider declarations has MURRAY RICHARD /CA/ filed?

MURRAY RICHARD /CA/ has filed 4 public insider declarations with SEC (Form 4).

What is MURRAY RICHARD /CA/'s role?

MURRAY RICHARD /CA/'s reported role is not specified by the regulator across the filings.

Which companies does MURRAY RICHARD /CA/ report trades for?

MURRAY RICHARD /CA/ reports trades for Jounce Therapeutics, Inc..

What is MURRAY RICHARD /CA/'s declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 173k€.

← Executives ★ Sign in to follow

MR

MURRAY RICHARD /CA/

Other

US·SEC (Form 4)

Jounce Therapeutics, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€172,793

▼ Sales (2 ops.)

Explore the detailed record of transactions filed by MURRAY RICHARD /CA/. Director active across 1 company, notably Jounce Therapeutics, Inc.. Cumulatively, 4 filings have been published. Split: 0 buy · 2 sells. Total volume traded: €173k. History available since 7 January 2022. The latest transaction was disclosed on 1 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.

Declarations4 total

◆

MURRAY RICHARD /CA/

CEO and PresidentExecutives1 Feb 2022Jounce Therapeutics, Inc.

22SEC ↗

87,500 shares0Common StockSEC:0001640455-22-000017:0

◆

MURRAY RICHARD /CA/

CEO and PresidentExecutives1 Feb 2022Jounce Therapeutics, Inc.

14SEC ↗

87,500 shares0Common StockSEC:0001640455-22-000017

▼

MURRAY RICHARD /CA/

CEO and PresidentExecutives7 Jan 2022Jounce Therapeutics, Inc.

$97,60140SEC ↗

13,370 shares@ US$7.30100.0% of flowCommon StockSEC:0001640455-22-000010

▼

MURRAY RICHARD /CA/

CEO and PresidentExecutives7 Jan 2022Jounce Therapeutics, Inc.

$97,60145SEC ↗

13,370 shares@ US$7.3050.0% of flowCommon StockSEC:0001640455-22-000010:0

4 of 4 declarations

InsidersTradesSigma

← Executives ★ Sign in to follow

MR

MURRAY RICHARD /CA/

Other

US·SEC (Form 4)

Jounce Therapeutics, Inc.

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€172,793

▼ Sales (2 ops.)

Explore the detailed record of transactions filed by MURRAY RICHARD /CA/. Director active across 1 company, notably Jounce Therapeutics, Inc.. Cumulatively, 4 filings have been published. Split: 0 buy · 2 sells. Total volume traded: €173k. History available since 7 January 2022. The latest transaction was disclosed on 1 February 2022 (Attribution). Regulator: SEC (Form 4). The full history is free.

Declarations4 total

◆

MURRAY RICHARD /CA/

CEO and PresidentExecutives1 Feb 2022Jounce Therapeutics, Inc.

22SEC ↗

87,500 shares0Common StockSEC:0001640455-22-000017:0

◆

MURRAY RICHARD /CA/

CEO and PresidentExecutives1 Feb 2022Jounce Therapeutics, Inc.

14SEC ↗

87,500 shares0Common StockSEC:0001640455-22-000017

▼